Skip to main content

and
Your search also matched 1 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Efficient and irreversible antibody–cysteine bioconjugation using carbonylacrylic reagents

Include preview-only content
  1. Article

    Open Access

    Author Correction: CD98hc is a target for brain delivery of biotherapeutics

    Kylie S. Chew, Robert C. Wells, Arash Moshkforoush, Darren Chan in Nature Communications (2023)

  2. Article

    Open Access

    CD98hc is a target for brain delivery of biotherapeutics

    Brain exposure of systemically administered biotherapeutics is highly restricted by the blood-brain barrier (BBB). Here, we report the engineering and characterization of a BBB transport vehicle targeting the ...

    Kylie S. Chew, Robert C. Wells, Arash Moshkforoush, Darren Chan in Nature Communications (2023)

  3. Article

    Open Access

    NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling

    T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with a dismal prognosis in patients with resistant or relapsed disease. Although NOTCH is a known driver in T-ALL, its clin...

    Inês Pinto, Mafalda Duque, Joana Gonçalves, Padma Akkapeddi in Oncogene (2020)

  4. Article

    Open Access

    A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological cancer for which treatment options often result in incomplete therapeutic efficacy and long-term side-effects. Interleukin 7 (IL-7) an...

    Padma Akkapeddi, Rita Fragoso, Julie A. Hixon, Ana Sofia Ramalho in Leukemia (2019)